A median of two (IQR: 1–3) imaging modalities wereused in order to assess inguinal LNs and metastatic disease, most commonly CT, in 78patients (98.7%); prostate MRI, in 30 (38.0%); bone scan, in 26 (32.9%); and PSMA PET/CT,in 18 (22.8%). Here, FOLH1 is linked to metastatic neoplasm.